Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 394 Neoplasms 351 Carcinoma, Non-Small-Cell Lung 303 Prostatic Neoplasms 255 Colorectal Neoplasms 226 Lung Neoplasms 197 Multiple Myeloma 162 Ovarian Neoplasms 152 Neoplasm Metastasis 146 Pancreatic Neoplasms 142 Leukemia, Myeloid, Acute 135 Melanoma 117 Squamous Cell Carcinoma of Head and Neck 98 Recurrence 96 Carcinoma, Renal Cell 94 Lymphoma 92 Endometrial Neoplasms 92 Brain Neoplasms 92 Lymphoma, Non-Hodgkin 91 Stomach Neoplasms 88 Carcinoma, Hepatocellular 87 Precursor Cell Lymphoblastic Leukemia-Lymphoma 85 Head and Neck Neoplasms 80 Glioblastoma 79 Uterine Cervical Neoplasms 78 Hematologic Neoplasms 76 Urinary Bladder Neoplasms 74 Leukemia, Lymphocytic, Chronic, B-Cell 74 Glioma 74 Triple Negative Breast Neoplasms 69

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × 30 days × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡